Comparing two heartburn medicines: tegoprazan vs pantoprazole
Treatments studied
Part of Digestive system clinical trials.
This study tests whether a newer medicine, tegoprazan, works better than an older one, pantoprazole, for treating heartburn and acid reflux. Both are stomach acid reducers. You may be able to join if you have been diagnosed with GERD and your symptoms have lasted for at least three months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with GERD (gastroesophageal reflux disease) or NERD (non-erosive reflux disease) through an endoscopy in the last 15 days.
- You have had a positive acid reflux test (impedance pHmetry) within the last 15 days.
- You have had heartburn and regurgitation (bringing food back up) for at least three months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer medication called vonoprazan against the standard treatment pantoprazole for patients with gastroesophageal reflux disease (GERD). The goal is to see which one works better for controlling symptoms like heartburn and acid reflux over 8 weeks.
This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
This study compares two medications, vonoprazan and esomeprazole, to see which works better for healing damage to the esophagus caused by acid reflux (erosive esophagitis). If you have this condition, this trial could help find you the most effective treatment.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This trial tests two medicines that lower stomach acid to help stop bleeding from the stomach or intestines. It aims to find which one works better for people with this type of bleeding.
Hear when a new GERD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.